Mean interval from initial diagnosis to initiation of non-pharmacological treatment by year. by Mingee Choi (15250732)

Subjects:

Task variability/correlations decrease independently of mean task activity removal step in fMRI data. by Takuya Ito (57473)

Elevated concentrations of serum MMA among participants with decreased cognitive performance. by Yige Liu (11940344)

Depleted antibody secreting cells did not result in decreased donor specific antibody in non-sensitized animals. by Natalie M. Bath (6316517)

“…(A) T (CD3⁺) and (B) B (CD45R⁺) cell flow crossmatch was performed in non-sensitized animals. IgG1⁺ in the T cell flow crossmatch was the only DSA that BLyS^-/- significantly decreased compared to APRIL^-/- (p<0.03). …”

Mean±SD of BTT and threshold in control, tinnitus and PBMT groups. by Katayoon Montazeri (18389243)

Subjects:

Treatment with pan-PKC inhibitor Gö-6983 resulted in a non-significant decrease in <i>GRK6</i> promoter activity. by Maike Stegen (8578665)

Tax expression is associated with decreased cellular motility. by Saumya Ramanayake (7879091)

Homozygous microdeletions of SNPs in the rs58923657 non-risk haplotype result in significantly decreased <i>IKZF1</i> expression and increased proliferation in human LCLs. by Vincent U. Gant (9955199)

Madrasin decreases transcription of protein-coding genes. by Michael Tellier (8284752)

CFU-Mk is significantly decreased by GATA1s overexpression in <i>GATA1s</i> strains. by Shiori Matsuo (10492159)

Annual treatment frequencies in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

Subjects:

Regenerating axons are increased by ATRA and decreased by clodronate. by Valeria De La Rosa-Reyes (6658613)

“…Compared to PBS-treated, the number of regenerating axons is doubled by ATRA treatment, decreased by 30% by clodronate, and, in the case of ATRA combined with clodronate, is not significantly different.…”

Annual number of outpatient visits in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

Subjects:

Laser irradiation in the PBMT group. by Katayoon Montazeri (18389243)

Subjects:

Between-groups comparison of GIN and PPI values in control, tinnitus and PBMT groups. by Katayoon Montazeri (18389243)

Subjects:

Diagram of methods. by Katayoon Montazeri (18389243)

Subjects:

Doublecortin (DCX) expression in 3 brain regions (coronal sections) in the control (Cont), Tinnitus (TIN) and PBMT (PBMT) groups. by Katayoon Montazeri (18389243)

Subjects:

PBMT parameters. by Katayoon Montazeri (18389243)

Subjects:

Fig 4 - by Katayoon Montazeri (18389243)

Subjects:

Bar graphs of DCX expression evaluated in three brain regions in the control (Cont), Tinnitus (TIN) and PBMT (PBMT) groups. by Katayoon Montazeri (18389243)

Subjects: